- Home
- VCIG vs APM Comparison
VCIG vs APM Comparison
Compare VCIG & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- APM
- Stock Information
- Founded
- VCIG 2013
- APM 2010
- Country
- VCIG Malaysia
- APM United Kingdom
- Employees
- VCIG N/A
- APM N/A
- Industry
- VCIG Diversified Commercial Services
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- APM Health Care
- Exchange
- VCIG Nasdaq
- APM Nasdaq
- Market Cap
- VCIG 22.5M
- APM 18.9M
- IPO Year
- VCIG 2023
- APM 2018
- Fundamental
- Price
- VCIG $2.55
- APM $1.59
- Analyst Decision
- VCIG
- APM
- Analyst Count
- VCIG 0
- APM 0
- Target Price
- VCIG N/A
- APM N/A
- AVG Volume (30 Days)
- VCIG 654.9K
- APM 400.5K
- Earning Date
- VCIG 10-06-2025
- APM 04-30-2025
- Dividend Yield
- VCIG N/A
- APM N/A
- EPS Growth
- VCIG N/A
- APM N/A
- EPS
- VCIG 270.67
- APM N/A
- Revenue
- VCIG $32,903,041.00
- APM N/A
- Revenue This Year
- VCIG N/A
- APM N/A
- Revenue Next Year
- VCIG N/A
- APM N/A
- P/E Ratio
- VCIG $0.01
- APM N/A
- Revenue Growth
- VCIG 24.77
- APM N/A
- 52 Week Low
- VCIG $2.54
- APM $0.46
- 52 Week High
- VCIG $4,644.00
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- VCIG 34.69
- APM 42.71
- Support Level
- VCIG $3.10
- APM $1.47
- Resistance Level
- VCIG $4.60
- APM $1.68
- Average True Range (ATR)
- VCIG 0.66
- APM 0.23
- MACD
- VCIG -0.49
- APM -0.06
- Stochastic Oscillator
- VCIG 0.00
- APM 14.41
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.